{"id":"https://openalex.org/W1965700705","doi":"https://doi.org/10.4161/cbt.7.9.6416","title":"Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo","display_name":"Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W1965700705","doi":"https://doi.org/10.4161/cbt.7.9.6416","mag":"1965700705","pmid":"https://pubmed.ncbi.nlm.nih.gov/18708754"},"language":"en","primary_location":{"id":"doi:10.4161/cbt.7.9.6416","doi":"https://doi.org/10.4161/cbt.7.9.6416","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.9.6416","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.9.6416?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.9.6416?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050872462","display_name":"Daniel Cejka","orcid":"https://orcid.org/0000-0001-7162-1443","observed_orcids":["https://orcid.org/0000-0001-7162-1443"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Daniel Cejka","raw_affiliation_strings":["Section of Experimental Oncology/Molecular Pharmacology, Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology, Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057141936","display_name":"Matthias Preusser","orcid":"https://orcid.org/0000-0003-3541-2315","observed_orcids":["https://orcid.org/0000-0003-3541-2315"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthias Preusser","raw_affiliation_strings":["Department of Internal Medicine I ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine I ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008270749","display_name":"Adelheid W\u00f6ehrer","orcid":"https://orcid.org/0000-0001-8435-8189","observed_orcids":["https://orcid.org/0000-0001-8435-8189"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Adelheid Woehrer","raw_affiliation_strings":["Institute of Neurology ; Medical University Vienna ; Vienna Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Neurology ; Medical University Vienna ; Vienna Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036486301","display_name":"Wolfgang Sieghart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Sieghart","raw_affiliation_strings":["Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089908971","display_name":"Sabine Strommer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sabine Strommer","raw_affiliation_strings":["Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090118471","display_name":"Johannes M. Werzowa","orcid":"https://orcid.org/0000-0003-2507-1377","observed_orcids":["https://orcid.org/0000-0003-2507-1377"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Werzowa","raw_affiliation_strings":["Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004872477","display_name":"Thorsten Fuereder","orcid":"https://orcid.org/0000-0001-5356-6452","observed_orcids":["https://orcid.org/0000-0001-5356-6452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thorsten Fuereder","raw_affiliation_strings":["Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009244604","display_name":"Volker Wacheck","orcid":"https://orcid.org/0000-0003-3962-5932","observed_orcids":["https://orcid.org/0000-0003-3962-5932"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Volker Wacheck","raw_affiliation_strings":["Department of Clinical Pharmacology ; Medical University Vienna ; Waehringer Guertel 18-20 ; Vienna 1090 Austria;","Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology ; Medical University Vienna ; Waehringer Guertel 18-20 ; Vienna 1090 Austria;","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Section of Experimental Oncology/Molecular Pharmacology ; Department of Clinical Pharmacology ;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2710,"currency":"EUR","value_usd":2970},"apc_paid":null,"fwci":2.0571,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.8635233,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"7","issue":"9","first_page":"1377","last_page":"1385"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.448199987411499,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.448199987411499,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.2856000065803528,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.19629999995231628,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8960000276565552},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/mtorc1-inhibition","display_name":"mTORC1 inhibition","score":0.8939999938011169},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.890999972820282},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.921999990940094},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.9419999718666077},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8500000238418579},{"id":"https://openalex.org/keywords/microvessel-density","display_name":"microvessel density","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8246236443519592},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7305452823638916},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.6575073003768921},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5452111959457397},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5027377605438232},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.4870791733264923},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4424028992652893},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3711377680301666},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36863940954208374},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3002091646194458},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27217984199523926},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08902493119239807},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009336","descriptor_name":"Necrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019394","descriptor_name":"Ki-67 Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020123","descriptor_name":"Sirolimus","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4161/cbt.7.9.6416","doi":"https://doi.org/10.4161/cbt.7.9.6416","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.9.6416","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.9.6416?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},{"id":"pmid:18708754","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18708754","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biology & therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/cbt.7.9.6416","doi":"https://doi.org/10.4161/cbt.7.9.6416","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.7.9.6416","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cbt.7.9.6416?needAccess=true&role=button","source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology &amp; Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1965700705.pdf","grobid_xml":"https://content.openalex.org/works/W1965700705.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068964160","https://openalex.org/W2183770925","https://openalex.org/W1966732445","https://openalex.org/W2967916541","https://openalex.org/W2063023121","https://openalex.org/W2019951496","https://openalex.org/W1997579388","https://openalex.org/W1992927350","https://openalex.org/W2098122003","https://openalex.org/W2143842256"],"abstract_inverted_index":{"Metronomic":[0],"dosing":[1],"of":[2,23,35,49,67,92,112,133,186,225,239,259],"cytotoxic":[3],"drugs":[4],"such":[5],"as":[6,135,137],"cyclophosphamide":[7,98,189,229],"has":[8],"shown":[9],"anti-angiogenic":[10,36,249],"activity,":[11],"most":[12],"likely":[13],"by":[14,43,237,248],"inducing":[15],"hypoxia":[16,246],"in":[17,54,58,82,94,101,139,143,161,191,214],"tumors.":[18],"Hypoxia":[19],"leads":[20,46],"to":[21,47,157,202,252],"activation":[22],"escape":[24],"mechanisms":[25],"allowing":[26],"tumor":[27,123,150,162,179,198,216],"cell":[28,73,86],"survival.":[29],"This":[30,152],"potentially":[31],"limits":[32],"the":[33,223],"activity":[34,57,91,154],"strategies.":[37],"We":[38],"hypothesized":[39],"that":[40],"mTORC1":[41,70],"inhibition":[42],"everolimus":[44,68,93,147,187,226,238],"(RAD001)":[45],"suppression":[48],"HIF-1alpha":[50,75,134,176],"and":[51,77,114,122,130,168,177,188,194,227],"VEGF":[52,78,138],"resulting":[53],"synergistic":[55,231],"anti-tumor":[56,90,153,232],"combination":[59,95,185,224],"with":[60,96,210],"anti-angiogenically":[61],"dosed":[62],"cyclophosphamide.":[63],"In":[64,88,145,221],"vitro,":[65],"effects":[66],"on":[69],"signaling,":[71],"proliferation,":[72,172],"cycle,":[74],"expression":[76],"secretion":[79],"were":[80],"evaluated":[81],"two":[83],"gastric":[84,105,140,260],"cancer":[85,106,141,235],"lines.":[87],"vivo,":[89,146],"metronomic":[97,228],"was":[99,155,208],"studied":[100],"a":[102,158,192,211,254],"NCI-N87":[103],"human":[104],"SCID":[107],"mouse":[108],"xenograft":[109],"model.":[110],"Expression":[111],"Ki-67":[113],"HIF-1alpha,":[115],"activated":[116],"caspase":[117],"3,":[118],"microvascular":[119],"density":[120],"(MVD)":[121],"necrotic":[124,163],"area":[125,164],"assessed.":[126],"Everolimus":[127],"decreased":[128,171,175],"proliferation":[129],"attenuated":[131],"production":[132],"well":[136],"cells":[142,236],"vitro.":[144],"significantly":[148],"inhibited":[149],"growth.":[151],"linked":[156],"significant":[159,196],"increase":[160,213],"(p":[165,181,204,218],"<":[166,205,219],"0.02)":[167],"trends":[169],"for":[170,242,257],"increased":[173],"apoptosis,":[174],"lower":[178],"MVD":[180],"=":[182],"n.s.).":[183],"The":[184],"resulted":[190],"striking":[193],"highly":[195],"long-term":[197],"growth":[199],"control":[200],"compared":[201],"monotherapy":[203],"0.001),":[206],"which":[207],"associated":[209],"sharp":[212],"central":[215],"necrosis":[217],"0.001).":[220],"conclusion,":[222],"showed":[230],"activity.":[233],"Depriving":[234],"factors":[240],"necessary":[241],"their":[243],"survival":[244],"under":[245],"induced":[247],"chemotherapy":[250],"appears":[251],"be":[253],"promising":[255],"approach":[256],"treatment":[258],"cancer.":[261]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2016-06-24T00:00:00"}